Aguilar-Valdés et al. (2023), reported the observation of EPLIN upregulation in pancreatic cancer cells, which were adaptive resistant to MEK and PI3K kinase targeted therapy37. This evidence concerns the gene LIMA1 and familial pancreatic carcinoma.